It was clearly overprice but apparently there was "rumour" of an offer for HER-Vaxx so likely this was a major cause of the extreme overvaluation despite the IP not even being close to completion of Ph2. I didn't invest in IMU because of HER-Vaxx (there might be still a big market for it and likely BP just want more clinical trial data), @fourdollars did so is disappointed there hasn't been any commercialisation deal attached for HER-Vaxx currently so has continue to whinge about it.
Why IMU is NOT a MULTI Bagger is a BAGGIES company, page-78
-
- There are more pages in this discussion • 17 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
